A data-driven ranking of the top healthcare stocks for 2026, based on live market data, fundamentals, and a four-factor quant model. Updated weekly. Not investment advice — research aid only.
Healthcare is the defensive growth sector — durable demand, multi-year drug pipelines, and demographic tailwinds. We rank big pharma alongside med-device leaders and managed-care names, with the factor composite favoring high-quality, dividend-paying compounders.
The current #1 pick on this list is JNJ (Johnson & Johnson), with a quant score of 63/100, 2.46% dividend yield, and $523.80B market cap. Below, you'll find the full top 10 ranking, individual analysis on the top 5, our methodology, and answers to common questions about healthcare stocks.
Top 10 Healthcare Stocks — Ranked
| Rank | Stock | Price | Market Cap | P/E | Yield | Quant Score |
|---|---|---|---|---|---|---|
| #1 |
JNJ
Johnson & Johnson
|
$217.41 | $523.80B | 0.00 | 2.46% | 63 |
| #2 |
PFE
Pfizer Inc.
|
$25.61 | $145.61B | 0.00 | 6.91% | 60 |
| #3 |
ABBV
AbbVie Inc.
|
$229.98 | $406.42B | 0.00 | 2.87% | 59 |
| #4 |
LLY
Eli Lilly and Company
|
$1077.75 | — | 0.00 | 0.00% | 46 |
| #5 |
MRK
Merck & Co., Inc.
|
$106.78 | — | 0.00 | 0.00% | 46 |
| #6 |
BMY
Bristol-Myers Squibb Company
|
$56.44 | — | 0.00 | 0.00% | 46 |
| #7 |
AMGN
Amgen Inc.
|
$326.41 | — | 0.00 | 0.00% | 46 |
| #8 |
CVS
CVS Health Corporation
|
$86.86 | — | 0.00 | 0.00% | 46 |
| #9 |
GILD
Gilead Sciences, Inc.
|
$130.50 | — | 0.00 | 0.00% | 46 |
| #10 |
REGN
Regeneron Pharmaceuticals, Inc.
|
$698.25 | — | 0.00 | 0.00% | 46 |
Top 5 Healthcare Stocks — In Depth
#1. Johnson & Johnson (JNJ)
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The…
#2. Pfizer Inc. (PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbre…
#3. AbbVie Inc. (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat …
#4. Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The compa…
#5. Merck & Co., Inc. (MRK)
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vacci…
How We Picked This List
This ranking is data-driven, not opinion-driven. Each stock was scored using:
- Primary ranking: composite factor score — a weighted blend of quality, value, momentum, and low volatility
- Universe: Curated list of 17 healthcare stocks — vetted for relevance and liquidity
- Quant score: Our factor composite (0–100) is shown alongside the primary ranking — use it as a sanity check on quality
All metrics pull from live market data and refresh weekly. We deliberately keep editorial influence to a minimum here — the list is what the numbers say.
Want to Compare These Healthcare Stocks Head-to-Head?
Use our free comparison tool to put any two stocks from this list side by side — 50+ metrics, AI-powered insights, no signup required.
Frequently Asked Questions
Disclaimer: This list is generated from live market data and our quantitative factor model for informational and educational purposes only. It is not investment advice, a recommendation to buy or sell any security, or a substitute for analysis by a licensed financial advisor. Past performance is not indicative of future results. Always read the most recent 10-K and consult a qualified professional before making investment decisions.